Semaglutide vs Tirzepatide

A physician-led comparison of the two leading GLP-1 weight-loss medications — how much weight you can expect to lose, side effects, dosing, and cost — to help you and your doctor choose the right fit.

Semaglutide vs tirzepatide: what's the difference?

Both semaglutide and tirzepatide are once-weekly injectable medications that help people lose weight by curbing appetite and slowing digestion. The core difference is how many hormone pathways they act on. Semaglutide (sold as Wegovy and Ozempic) mimics a single hormone, GLP-1. Tirzepatide (sold as Zepbound and Mounjaro) is a dual-agonist that activates both GLP-1 and a second hormone, GIP — giving it a broader effect on appetite and blood-sugar regulation.

Efficacy: how much weight can you lose?

In clinical trials, tirzepatide has produced the larger average weight loss. Adults on the highest tirzepatide dose lost roughly 20–22% of their body weight over about 72 weeks in the SURMOUNT-1 study, while semaglutide averaged around 15% over 68 weeks in STEP-1. That makes tirzepatide the more powerful option on average — but semaglutide still delivers substantial, life-changing results for most people, and individual response varies widely based on genetics, dose, diet, and activity.

Side effects and dosing

The two medications share a similar side-effect profile — most commonly nausea, diarrhea, constipation, and reduced appetite, usually during dose increases and usually improving over time. Both are started at a low dose and titrated up gradually to help your body adjust and minimize GI symptoms. Because tirzepatide is often more potent, some patients experience stronger effects at higher doses. Eating smaller, lower-fat meals and staying hydrated helps with either medication.

Cost and which one to choose

Compounded semaglutide is generally the more affordable starting point, while tirzepatide is typically priced higher for its dual-action potency. The best choice depends on your goals, medical history, side-effect tolerance, and budget — a decision best made with a physician. Many patients start on semaglutide and switch to tirzepatide to push past a plateau, while others begin with tirzepatide for maximum results. At GOAL.MD, pricing is transparent and all-inclusive, with no auto-billing.

Frequently asked questions

Is tirzepatide more effective than semaglutide for weight loss?

In head-to-head research, tirzepatide (Zepbound, Mounjaro) has produced greater average weight loss than semaglutide (Wegovy, Ozempic). In the SURMOUNT-1 trial, adults on the highest tirzepatide dose lost about 20–22% of their body weight over ~72 weeks, while semaglutide in the STEP-1 trial averaged around 15% over 68 weeks. Tirzepatide activates two hormone pathways (GIP and GLP-1) versus semaglutide's single GLP-1 pathway, which is thought to drive the difference. That said, individual results vary widely, and many people reach their goals on semaglutide.

What is the difference between semaglutide and tirzepatide?

Semaglutide is a single-agonist that mimics GLP-1, a hormone that curbs appetite and slows stomach emptying. Tirzepatide is a dual-agonist that activates both GLP-1 and GIP receptors, giving it a broader effect on appetite and blood-sugar control. Both are once-weekly injections, both require a prescription and physician oversight, and both are titrated up slowly to reduce side effects.

Do semaglutide and tirzepatide have different side effects?

The side-effect profiles are similar. Both most commonly cause nausea, diarrhea, constipation, vomiting, and reduced appetite, especially during dose increases. These are usually mild-to-moderate and improve over time. Because tirzepatide is often more potent, some people notice stronger GI effects at higher doses. Slow titration, smaller lower-fat meals, and hydration help with both medications.

Which is cheaper, semaglutide or tirzepatide?

Compounded semaglutide programs are generally the lower-cost option, with tirzepatide typically priced higher because of its dual-action potency. At GOAL.MD, all pricing is transparent and all-inclusive — no auto-billing and no hidden fees. Compare current pricing on our semaglutide and tirzepatide program pages.

How do I choose between semaglutide and tirzepatide?

The right choice depends on your weight-loss goals, medical history, tolerance to side effects, and budget — which is why it should be made with a physician. Some people start with semaglutide and switch to tirzepatide if they need more, while others begin with tirzepatide for maximum results. A GOAL.MD physician reviews your health assessment and recommends the best fit for you.

Can I switch from semaglutide to tirzepatide?

Yes, many patients switch — often to break through a plateau or to pursue greater weight loss. Switching should always be supervised by a physician, who will set the correct starting dose and titration schedule for the new medication to minimize side effects.

This guide provides general educational information and is not medical advice. Weight-loss results and medication suitability vary by individual health status. Compounded medications are not FDA-approved. All treatments require a physician evaluation and prescription. Talk to a licensed physician before starting or changing any medication.

Medically reviewed by Dr. Michael Mimlitz, MD (NPI 1508891870), Chief Physician of GOAL.MD. Physician-supervised telehealth. More at goal.md/guides.